TCRX — Tscan Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Tscan Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	34.8	161	120	192	290
Prepaid Expenses
Total Current Assets	36.4	166	124	194	293
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.5	17.3	69.2	71.2	71.6
Long Term Investments
Other Long Term Assets
Total Assets	49.7	188	199	272	371
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.4	21.3	17.3	29.8	36
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	32.5	27.3	99.7	121	130
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.2	161	99.4	151	241
Total Liabilities & Shareholders' Equity	49.7	188	199	272	371
Total Common Shares Outstanding